معرفی
Dr. Michael Henry is a Research Fellow at the School of Biotechnology, Dublin City University (Glasnevin Campus). His primary research focuses on proteomics, cell biology, and biopharmaceutical production. He specializes in advanced mass spectrometry-based techniques to study protein modifications, cellular stress responses, and disease mechanisms in recombinant systems like Chinese Hamster Ovary (CHO) cells.
Key research areas include:
- Proteomic profiling of disease models (e.g., Duchenne muscular dystrophy, pancreatic cancer)
- Biopharmaceutical process optimization through proteomic analysis
- Post-translational modification characterization (ubiquitination, phosphorylation, citrullination)
- Biomarker discovery in oncology and metabolic disorders
His work integrates multi-omic approaches to bridge basic science and translational applications, with recent contributions to understanding ER stress responses in biomanufacturing systems and developing novel diagnostic panels for pancreatic cancer progression.
Dr. Henry's lab develops innovative sample preparation protocols for improved proteomic analysis, including methods for complex biological matrices like urine extracellular vesicles and intestinal cell cultures. His research also explores the molecular basis of growth-related phenotypes in industrial cell lines.
